Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up

Published:2016-04 Issue:3 Volume:156 Page:501-506
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Murtagh G.,Lyons T.,O’Connell E.,Ballot J.,Geraghty L.,Fennelly D.,Gullo G.,Ledwidge M.,Crown J.,Gallagher J.,Watson C.,McDonald K. M.,Walshe J. M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3781-4.pdf

Reference33 articles.

1. Chen MH, Colan SD, Diller L (2011) Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res 108(5):619–628

2. Von Hoff DD, Layard MW et al (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91(5):710–717

3. Ho E, Brown A, Barrett P et al (2010) Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 96(9):701–707

4. Smith LA, Cornelius VR, Plummer CJ et al (2010) Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer 10:337

5. Nagueh SF, Middleton KJ, Kopelen HA et al (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30(6):1527–1533

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UNC13B regulates the sensitivity of Wilms' tumor cells to doxorubicin by modulating lysosomes;Oncology Letters;2024-07-22

2. Characteristics and research status among clinical trials in cardio‐oncology by bibliometric and visualized analysis;Cancer Medicine;2023-05-06

3. Physical Inactivity, Adverse Body Composition, and Cardiac Function in Breast Cancer Survivors;JACC: CardioOncology;2022-06

4. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction;Cardiovascular Research;2022-05-31

5. Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells;Cancer Research and Treatment;2022-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3